Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin therapy for the primary prevention of cardiovascular disease: Pros
Alexander C. Razavi, Anurag Mehta, Laurence S. Sperling
Atherosclerosis (2022) Vol. 356, pp. 41-45
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk
Jaejin An, Yiyi Zhang, Hui Zhou, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 7, pp. 623-632
Open Access | Times Cited: 23
Continuous Positive Airway Pressure but Not GLP1-mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study
Cliona O’Donnell, Shane Crilly, Anne O’Mahony, et al.
Annals of the American Thoracic Society (2023) Vol. 21, Iss. 3, pp. 464-473
Closed Access | Times Cited: 18
Impact of therapeutic inertia in lipid-lowering therapy in patients at very high cardiovascular risk
Juan Cosı́n-Sales, Carlos Escobar Cervantes, José J. Gómez-Barrado, et al.
Clínica e Investigación en Arteriosclerosis (2025), pp. 500773-500773
Closed Access
Lipoprotein(a): Role in atherosclerosis and new treatment options
Dragana Tomić Naglić, Mia Manojlović, Sladjana Pejaković, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 10
Food-derived peptides with inhibitory capacity for HMG-CoA reductase activity: a potential nutraceutical for hypercholesterolemia
Guillermo Santos Sánchez, Ana Isabel Álvarez López, Eduardo Ponce España, et al.
Deleted Journal (2024)
Open Access | Times Cited: 3
Acute coronary syndrome patterns in the Young: risk factor profile and in-hospital outcomes in a tertiary referral hospital in Kenya
Nadeem Kassam, Mzee Ngunga, Mohamed Hasham Varwani, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals
Andrea Poli, Alberico L. Catapano, Alberto Corsini, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 33, Iss. 2, pp. 245-257
Open Access | Times Cited: 14
Genome-wide association study of therapeutic response to statin drugs in cardiovascular disease
Hamed Dabiri, Zahra Mortezaei
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review
Yura Kang, Jung Mi Park, Sang‐Hak Lee
Yonsei Medical Journal (2023) Vol. 65, Iss. 1, pp. 19-19
Open Access | Times Cited: 6
Atorvastatin Can Modulate DNA Damage Repair in Endothelial Cells Exposed to Mitomycin C
M. Yu. Sinitsky, М. А. Асанов, А. V. Sinitskaya, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6783-6783
Open Access | Times Cited: 4
Genomic Insights Into Statin Therapy: Differential Expression Analysis of Key Genes
Maryam Mahjoubin‐Tehran, Vasily N. Sukhorukov, Tannaz Jmaialahmadi, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102103-102103
Closed Access | Times Cited: 4
Simultaneous determination of BGT-002 and its acyl glucuronide metabolite ZM326E-M2 in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study
Xueran Zhu, Shumin Cui, Xinjing Liu, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 243, pp. 116056-116056
Closed Access | Times Cited: 1
Impact of CYP2C19 Gene Variants on Long-Term Treatment with Atorvastatin in Patients with Acute Coronary Syndromes
Darius Čereškevičius, Vytautas Zabiela, Ali Aldujeli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5385-5385
Open Access | Times Cited: 1
With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?
Anurag Mehta, Dave L. Dixon, Anum Saeed, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 5, pp. 423-430
Closed Access | Times Cited: 3
Rosuvastatin relaxes rat thoracic aorta, pulmonary artery, and trachea via nitric oxide, prostanoids, and potassium channels
Serdar Şahintürk
Çukurova medical journal (Online)/Çukurova medical journal (2023) Vol. 48, Iss. 2, pp. 419-431
Open Access | Times Cited: 3
Continuous positive airway pressure but not Liraglutide-mediated weight loss improves early cardiovascular disease in obstructive sleep apnea: Data from a randomized proof-of-concept study
Cliona O’Donnell, Shane Crilly, Anne O’Mahony, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Comparative Effects of Rosuvastatin and Atorvastatin Loading Doses on Immediate Post-percutaneous Coronary Intervention (PCI) Thrombolysis in Myocardial Infarction (TIMI) Flow in ST-Segment Elevation Myocardial Infarction (STEMI) Patients
Ahmed Jamal Chaudhary, Sana Iqbal, Nisar Ahmad Khan, et al.
Cureus (2024)
Open Access
Risk of Sarcopenia Following Long‐Term Statin Use in Community‐Dwelling Middle‐Aged and Older Adults in Japan
Shih‐Tsung Huang, Rei Otsuka, Yukiko Nishita, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 16, Iss. 1
Open Access
Coronary artery calcium density progression: Should we measure it?
Alexander C. Razavi, Roger S. Blumenthal, Mouaz H. Al‐Mallah, et al.
Atherosclerosis (2024), pp. 118618-118618
Closed Access
Diabetic adverse events associated with three commonly used statins: a disproportionality analysis based on the FDA adverse event reporting system database
Bin Deng, Shijun Li, Ruxu You, et al.
Expert Opinion on Drug Safety (2024), pp. 1-8
Closed Access
Low Cholesterol Levels in Younger Heart Failure Patients May Predict Unfavorable Outcomes
Lior Charach, Itamar Grosskopf, Leonid Galin, et al.
Medicina (2023) Vol. 59, Iss. 7, pp. 1314-1314
Open Access | Times Cited: 1
Computationally Modelling Cholesterol Metabolism and Atherosclerosis
Callum Davies, A. Morgan, Mark T. Mc Auley
Biology (2023) Vol. 12, Iss. 8, pp. 1133-1133
Open Access | Times Cited: 1
The Complementary Effects of Dabigatran Etexilate and Exercise Training on the Development and Stability of the Atherosclerotic Lesions in Diabetic ApoE Knockout Mice
Nikolaos P.E. Kadoglou, Marianna Stasinopoulou, Evangelia Gkougkoudi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1396-1396
Open Access | Times Cited: 1
Modern algorithms for statin therapy
Andrey V. Susekov
Russian Journal of Cardiology (2023) Vol. 28, Iss. 10, pp. 5594-5594
Open Access | Times Cited: 1
Statin Therapy for The Primary Prevention of Cardiovascular Disease: Pros
Sidhi Laksono, Fadhilla Umami, Zahra Nurusshofa, et al.
Journal of Drug Delivery and Therapeutics (2022) Vol. 12, Iss. 5-S, pp. 5-8
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top